Company news

ADVANZ PHARMA Corp. Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

ADVANZ PHARMA makes key changes to senior leadership to further accelerate next phase of growth

November 18, 2021

Nordic Capital Acquires Specialty Pharmaceutical Company ADVANZ PHARMA in Deal Worth ~$846 Million

June 1, 2021

ADVANZ PHARMA Corp. Limited Announces First Quarter 2021 Results

May 14, 2021

ADVANZ PHARMA Corp. Limited Announces Fourth Quarter and 2020 Results

March 17, 2021

ADVANZ PHARMA Corp. Limited Announces Agreement Of Terms To Be Acquired By Nordic Capital

January 27, 2021

ADVANZ PHARMA Corp. Limited Announces Third Quarter 2020 Results

November 6, 2020

ADVANZ Pharma Corp. Limited ("ADVANZ" or the "Company") - Formal Sale Process

October 23, 2020

ADVANZ PHARMA Corp. Limited Announces Release Date for Third Quarter 2020 Results

October 23, 2020

ADVANZ PHARMA Corp. Limited Announces Second Quarter 2020 Results

August 12, 2020

ADVANZ PHARMA Corp. Limited Announces Release Date for Second Quarter 2020 Results

July 29, 2020

ADVANZ PHARMA Corp. Limited Announces Results of Annual Meeting of Shareholders

June 17, 2020

Correvio Provides Update Pursuant to BCI 51-515 - Temporary Exemption from Certain Corporate Finance Requirements

June 15, 2020

ADVANZ PHARMA Corp. Limited Closes Acquisition of Specialty Pharmaceutical Company Correvio Pharma Corp.

May 27, 2020

ADVANZ PHARMA Corp. Limited Announces First Quarter 2020 Results

May 13, 2020

ADVANZ PHARMA Corp. Limited Announces Release Date for First Quarter 2020 Results

April 29, 2020

ADVANZ PHARMA Corp. Limited Closes Acquisition of the Rights to a Portfolio of Alprostadil Products from UCB S.A. for $83 Million

April 1, 2020

ADVANZ PHARMA Corp. Limited Completes Voluntarily Delisting from the Toronto Stock Exchange

March 27, 2020

ADVANZ PHARMA Corp. Limited Announces Fourth Quarter and 2019 Results

March 25, 2020

ADVANZ PHARMA Corp. Limited to Acquire Specialty Pharmaceutical Company Correvio Pharma Corp.

March 16, 2020

ADVANZ PHARMA Corp. Limited Announces Release Date for Fourth Quarter and 2019 Results

March 11, 2020

ADVANZ PHARMA Corp. Limited to Voluntarily Delist from the Toronto Stock Exchange

March 10, 2020

ADVANZ PHARMA Corp. Limited Announces Definitive Agreement to Acquire The Rights To A Portfolio Of Alprostadil Products From UCB S.A. For Approximately $84 Million

March 6, 2020

ADVANZ PHARMA Corp. Limited Comments on CMA Supplemental Statement of Objections Related to Hydrocortisone Tablets

February 12, 2020

ADVANZ PHARMA Announces Changes to its Board of Directors and Completion of its Continuance to Western Europe

January 8, 2020

ADVANZ PHARMA Corp. Announces Results of Special Meeting of Shareholders

December 17, 2019

ADVANZ PHARMA Corp. Announces Proposal to Re-domicile from Canada to Europe

November 27, 2019

ADVANZ PHARMA Corp. Announces Release Date for Third Quarter 2019 Results

October 24, 2019

ADVANZ PHARMA Corp. Announces Second Quarter 2019 Results

August 7, 2019

ADVANZ PHARMA Corp. Comments on CMA Statement of Objections Related to Nitrofurantoin

July 25, 2019

ADVANZ PHARMA Corp. Announces Release Date for Second Quarter 2019 Results

July 24, 2019

ADVANZ PHARMA Corp. Announces Results of Annual Meeting of Shareholders

June 17, 2019

ADVANZ PHARMA Corp. Announces Non-Deal Roadshow for European-based Debt Investors

June 11, 2019

ADVANZ PHARMA Corp. Comments on CMA Statement of Objections Related to Prochlorperazine

May 23, 2019

ADVANZ PHARMA Corp. Announces First Quarter 2019 Results

May 10, 2019

ADVANZ PHARMA Corp. Announces Release Date for First Quarter 2019 Results

April 26, 2019

ADVANZ PHARMA Corp. Acquires International Rights to Two Medicines

April 1, 2019

ADVANZ PHARMA Corp. Announces Fourth Quarter and Fiscal 2018 Results

March 14, 2019

ADVANZ PHARMA Corp. Announces Release Date for Fourth Quarter and 2018 Results

February 21, 2019

ADVANZ PHARMA Corp. Comments on CMA Supplemental Statement of Objections

January 30, 2019

Concordia International Corp. Announces Name Change to ADVANZ PHARMA Corp.

November 29, 2018

Concordia International Corp. Announces Intention To Rebrand As ADVANZ PHARMA Following Its Successful Recapitalization

October 9, 2018

S&P Dow Jones Indices Announces Changes to the S&P/TSX Canadian Indices

September 9, 2016

Concordia Healthcare Completes US$520 Million Public Offering of Common Shares at US$65.00 per Common Share

September 30, 2015

Concordia Healthcare Announces Terms of US$520 Million Public Offering of Common Shares

September 24, 2015

Concordia Healthcare Announces Public Offering of Common Shares

September 21, 2015

S&P Dow Jones Indices Announces Changes to the S&P/TSX Canadian Indices

March 13, 2015

S&P Dow Jones Indices Announces Changes to the S&P/TSX Canadian Indices

September 12, 2014

Decks